| # | Drug | Count |
|---|---|---|
| 0 | ALLOPURINOL | 14 |
| 1 | APIXABAN | 14 |
| 2 | BISOPROLOL FUMARATE | 14 |
| 3 | TORSEMIDE | 14 |
| 4 | WARFARIN | 14 |
| 5 | DOBUTAMINE | 13 |
| 6 | EPLERENONE | 13 |
| 7 | FINASTERIDE | 13 |
| 8 | INSULIN HUMAN | 13 |
| 9 | TELMISARTAN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SERTACONAZOLE NITRATE | 1 | 0.0062 |
| 1 | CAFFEINE, MAGNESIUM SALICYLATE | 1 | 0.0039 |
| 2 | DOBUTAMINE | 13 | 0.0034 |
| 3 | PAMABROM | 1 | 0.0027 |
| 4 | EPLERENONE | 13 | 0.0010 |
| 5 | TELMISARTAN | 13 | 0.0007 |
| 6 | TAFAMIDIS MEGLUMINE | 2 | 0.0004 |
| 7 | TORSEMIDE | 14 | 0.0004 |
| 8 | INSULIN HUMAN | 13 | 0.0003 |
| 9 | MIDODRINE HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Loop Diuretic [EPC] | 17 |
| 1 | Factor Xa Inhibitor [EPC] | 15 |
| 2 | Aldosterone Antagonist [EPC] | 14 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 14 |
| 4 | Xanthine Oxidase Inhibitor [EPC] | 14 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 13 |
| 6 | Insulin [EPC] | 13 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 12 |
| 8 | Kinase Inhibitor [EPC] | 7 |
| 9 | Proton Pump Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin [EPC] | 13 | 0.0003 |
| 1 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 13 | 0.0001 |
| 3 | Aldosterone Antagonist [EPC] | 14 | 0.0001 |
| 4 | Xanthine Oxidase Inhibitor [EPC] | 14 | 0.0001 |
| 5 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 6 | Factor Xa Inhibitor [EPC] | 15 | 0.0001 |
| 7 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Angiotensin 2 Receptor Blocker [EPC] | 14 | 0.0000 |
| 9 | Typical Antipsychotic [EPC] | 1 | 0.0000 |